Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Dominik Koch

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Science of Aging Knowledge Environment : SAGE KE|December 2, 2005
T Cell Immunity and AgingSven Dominik Koch, Juergen Kempf, Graham Pawelec
Lancet (London, England)|July 30, 2017
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trialMartin Alberer, Ulrike Gnad-Vogt, Henoch Sangjoon Hong, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Science of Aging Knowledge Environment : SAGE KE|December 2, 2005
T Cell Immunity and AgingSven Dominik Koch, Juergen Kempf, Graham Pawelec
Lancet (London, England)|July 30, 2017
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trialMartin Alberer, Ulrike Gnad-Vogt, Henoch Sangjoon Hong, et al.
Pageof 1